Dren Bio develops engineered antibody therapeutics designed to selectively deplete pathogenic cells and other disease-causing agents. Its pipeline includes clinical-stage programs in oncology and autoimmune diseases, along with preclinical and discovery programs in oncology, immunology, and neurology.

Jobs

See all jobs for Dren Bio here.

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Leads

Participating Firms

Angels